UTHR
United Therapeutics Corporation
494.60$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 9.8% | 4.7% | 4.5% | 6.1% | 12.2% | 8.1% | 7.3% | 7.3% | 7.6% | 11.1% | 10.8% | 12.1% | |
| 90.2% | 95.3% | 95.5% | 93.9% | 87.8% | 91.9% | 92.7% | 92.7% | 92.4% | 88.9% | 89.2% | 87.9% | |
| 18.8% | 16.7% | 9.2% | 15.3% | 22.0% | 81.6% | 24.1% | 32.0% | 16.7% | 17.5% | 16.7% | 17.3% | |
| 23.2% | 24.4% | 14.5% | 15.4% | 12.7% | 19.0% | 24.9% | 23.9% | 21.5% | 17.0% | 18.8% | 19.2% | |
| 48.4% | 47.6% | 29.0% | 34.5% | 38.3% | 104.8% | 52.7% | 59.8% | 41.8% | 38.0% | 41.4% | 40.3% | |
| 41.8% | 47.7% | 66.4% | 47.2% | 49.5% | -12.9% | 40.0% | 33.0% | 50.6% | 50.9% | 47.9% | 47.7% | |
| 1.4% | 0.3% | 0.2% | 0.5% | 0.9% | 3.1% | 1.6% | 1.1% | 1.7% | 2.5% | 1.5% | 0.6% | |
| 40.8% | 71.3% | 66.3% | 44.6% | 46.6% | -11.4% | 43.1% | 35.2% | 49.1% | 54.7% | 53.5% | 53.9% | |
| 14.4% | 26.8% | 21.7% | 20.4% | 10.4% | -4.2% | 8.4% | 7.0% | 11.5% | 12.4% | 12.0% | 11.9% | |
| 26.4% | 44.5% | 44.6% | 24.2% | 36.2% | -7.2% | 34.7% | 28.2% | 37.6% | 42.3% | 41.5% | 41.9% | |
| 44.6% | 73.8% | 68.2% | 61.1% | 51.5% | -5.2% | 43.6% | 43.7% | 53.7% | 59.6% | 57.5% | 57.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.